Arora M

No ORCID on file · 5 papers in corpus · active 2019-2026
2026
Integrating meaningful involvement of people living with non-communicable diseases in India's National NCD Programme: lessons learnt and opportunities for global, regional and national contextualisation and adoption.
BMJ global health ·doi:10.1136/bmjgh-2025-020189

Globally, the burden of non-communicable diseases (NCDs) continues to rise and disproportionately affect low- and middle-income countries (LMICs). Despite clinical, technological and digital advances in health systems, these remain underuti…

2024
Diffusion-weighted Imaging: New Paradigm in Diagnosis of Early Acute Pancreatitis.
Annals of African medicine ·doi:10.4103/aam.aam_79_24

BackgroundDiffusion-weighted imaging (DWI) has come up as a newer diagnostic modality for the diagnosis of early functional changes in various organs including the pancreas. DWI has shown the ability of early and accurate diagnosis of infla…

2023
Can Peer-based Interventions Improve Adolescent Sexual and Reproductive Health Outcomes? An Overview of Reviews.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine ·doi:10.1016/j.jadohealth.2023.05.035

PurposeAn overview of reviews was conducted to summarize the evidence and synthesize the results from systematic reviews.MethodsThe Cochrane and Preferred Reporting Items for Overviews of Reviews reporting guidelines were followed and the p…

2023
Exposure to perfluoroalkyl substances and women's fertility outcomes in a Singaporean population-based preconception cohort.
The Science of the total environment ·doi:10.1016/j.scitotenv.2023.162267

ObjectivesExperimental models have demonstrated a link between exposure to perfluoroalkyl substances (PFAS) and decreased fertility and fecundability; however, human studies are scarce. We assessed the associations between preconception pla…

2019
A Multicenter, Randomized, Equivalence Trial of a New Recombinant Human Chorionic Gonadotropin Preparation versus Ovitrelle® for Ovulation in Women Undergoing Intrauterine Insemination Following Ovarian Stimulation.
Journal of human reproductive sciences ·doi:10.4103/jhrs.jhrs_101_18

ContextA new indigenous recombinant human chorionic gonadotropin (r-hCG) has been developed in India with a comparable pharmacological profile to that of Ovitrelle® (Merck Serono).AimsThis study aims to compare the efficacy and safety of th…